{
    "organizations": [],
    "uuid": "814f19aa191ca64bb10dadb59562bd7e472ad4e4",
    "author": "",
    "url": "https://www.reuters.com/article/brief-psivida-corp-announces-transformat/brief-psivida-corp-announces-transformative-acquisition-of-icon-bioscience-idUSASC09U27",
    "ord_in_thread": 0,
    "title": "BRIEF-pSivida Corp Announces Transformative Acquisition Of Icon Bioscience",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 28, 2018 / 8:35 PM / Updated 5 minutes ago BRIEF-pSivida Corp Announces Transformative Acquisition Of Icon Bioscience Reuters Staff 2 Min Read \nMarch 28 (Reuters) - pSivida Corp: \n* PSIVIDA CORP ANNOUNCES TRANSFORMATIVE ACQUISITION OF ICON BIOSCIENCE INC AND GROWTH CAPITAL FINANCING WITH ESSEX WOODLANDS HEALTHCARE PARTNERS â€“ COMPANY WILL REBRAND AS EYEPOINT PHARMACEUTICALS INC \n* PSIVIDA CORP - SWK HOLDINGS WILL PROVIDE UP TO $20 MILLION IN DEBT FINANCING \n* PSIVIDA CORP - DEAL FOR APPROXIMATELY $60.5 MILLION \n* PSIVIDA CORP - PSIVIDA CORP. WILL REBRAND AND CHANGE ITS NAME TO EYEPOINT PHARMACEUTICALS INC. \n* PSIVIDA CORP - ENTERED INTO A FINANCIAL AGREEMENT WITH EW HEALTHCARE PARTNERS \n* PSIVIDA CORP - EW HEALTHCARE PARTNERS AND A THIRD PARTY INVESTOR WILL MAKE EQUITY INVESTMENTS IN PSIVIDA \n* PSIVIDA CORP - WILL USE FUNDS TO FINANCE ICON ACQUISITION AND PREPARE FOR COMMERCIAL LAUNCHES OF DEXYCU \n* PSIVIDA CORP - IF APPROVED, PSIVIDA EXPECTS TO LAUNCH DURASERT IN U.S. IN FIRST HALF OF 2019 \n* PSIVIDA CORP - PSIVIDA PLANS TO LAUNCH DEXYCU IN U.S. IN FIRST HALF OF 2019 \n* PSIVIDA CORP - EW HEALTHCARE PARTNERS AND A THIRD PARTY INVESTOR WILL MAKE AN EQUITY INVESTMENT IN PSIVIDA FOR UP TO ABOUT $60.5 MILLION Source text for Eikon: Further company coverage:",
    "published": "2018-03-28T23:32:00.000+03:00",
    "crawled": "2018-03-28T23:50:57.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "corp",
        "announces",
        "transformative",
        "acquisition",
        "icon",
        "bioscience",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "psivida",
        "corp",
        "psivida",
        "corp",
        "announces",
        "transformative",
        "acquisition",
        "icon",
        "bioscience",
        "inc",
        "growth",
        "capital",
        "financing",
        "essex",
        "woodland",
        "healthcare",
        "partner",
        "company",
        "rebrand",
        "eyepoint",
        "pharmaceutical",
        "inc",
        "psivida",
        "corp",
        "swk",
        "holding",
        "provide",
        "million",
        "debt",
        "financing",
        "psivida",
        "corp",
        "deal",
        "approximately",
        "million",
        "psivida",
        "corp",
        "psivida",
        "rebrand",
        "change",
        "name",
        "eyepoint",
        "pharmaceutical",
        "psivida",
        "corp",
        "entered",
        "financial",
        "agreement",
        "ew",
        "healthcare",
        "partner",
        "psivida",
        "corp",
        "ew",
        "healthcare",
        "partner",
        "third",
        "party",
        "investor",
        "make",
        "equity",
        "investment",
        "psivida",
        "psivida",
        "corp",
        "use",
        "fund",
        "finance",
        "icon",
        "acquisition",
        "prepare",
        "commercial",
        "launch",
        "dexycu",
        "psivida",
        "corp",
        "approved",
        "psivida",
        "expects",
        "launch",
        "durasert",
        "first",
        "half",
        "psivida",
        "corp",
        "psivida",
        "plan",
        "launch",
        "dexycu",
        "first",
        "half",
        "psivida",
        "corp",
        "ew",
        "healthcare",
        "partner",
        "third",
        "party",
        "investor",
        "make",
        "equity",
        "investment",
        "psivida",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}